Cimifugin relieves the relapse of allergic asthma via inhibiting ILC2 migration by targeting CCR9
Fields of Study & Subjects
IL-33
ST2
and ILC Pathways
Asthma and respiratory diseases
Eosinophilic Esophagitis
Publication details
- Journal / source
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Volume
- 363
- Pages
- 121429–121429
- Publication date
- 4 March 2026
- Language
- EN